A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection

Human Immunology

Volumn 72, Issue 3, 2011, Pages 273-277

  Lettow, Iris ^a   Berres, Marie Luise ^a   Schmitz, Petra ^a   Müller, Tobias ^b   Berg, Thomas ^b   Neumann, Ulf P ^b   Trautwein, Christian ^a   Wasmuth, Hermann E ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokine scavenging; Chemokines; Hepatitis C; Liver fibrosis

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DARC GENE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEPTOR GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHEMOKINE CCL2; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; RISK FACTORS;

EID: 79651473196     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.12.002     Document Type: Article

References (36)

1. Dienstag J.L., McHutchison J.G. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006, 130:231-264.
2. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349:825-832.
3. Asselah T., Bieche I., Paradis V., Bedossa P., Vidaud M., Marcellin P. Genetics, genomics, and proteomics: Implications for the diagnosis and the treatment of chronic hepatitis C. Semin Liver Dis 2007, 27:13-27.
4. Huang H., Shiffman M.L., Friedman S., Venkatesh R., Bzowej N., Abar O.T., et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatol 2007, 46:297-306.
5. Marcolongo M., Young B., Dal Pero F., Fattovich G., Peraro L., Guido M., et al. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatol 2009, 50:1038-1044.
6. Heydtmann M., Adams D.H. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatol 2009, 49:676-688.
7. Zeremski M., Petrovic L.M., Talal A.H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 2007, 14:675-687.
8. Wasmuth H.E., Zaldivar M.M., Berres M.L., Werth A., Scholten D., Hillebrandt S., et al. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J Hepatol 2008, 48:208-215.
9. Wasmuth H.E., Lammert F., Zaldivar M.M., Weiskirchen R., Hellerbrand C., Scholten D., et al. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 2009, 137:309-319.
10. Promrat K., McDermott D.H., Gonzalez C.M., Kleiner D.E., Koziol D.E., Lessie M., et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003, 124:352-360.
11. Hellier S., Frodsham A.J., Hennig B.J., Klenerman P., Knapp S., Ramaley P., et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatol 2003, 38:1468-1476.
12. Berres M.L., Koenen R.R., Rueland A., Zaldivar M.M., Heinrichs D., Sahin H., et al. Antagonism of the chemokine CCL5 ameliorates experimental liver fibrosis in mice. J Clin Invest 2010, 120:4129-4140.
13. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am J Pathol 1998, 152:423-430.
14. Marra F., Romanelli R.G., Giannini C., Failli P., Pastacaldi S., Arrighi M.C., et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatol 1999, 29:140-148.
15. Karlmark K.R., Weiskirchen R., Zimmermann H.W., Gassler N., Ginhoux F., Weber C., et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatol 2009, 50:261-274.
16. Seki E., de Minicis S., Inokuchi S., Taura K., Miyai K., van Rooijen N., et al. CCR2 promotes hepatic fibrosis in mice. Hepatol 2009, 50:185-197.
17. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasler W.E., Weiss T.S., Herfarth H., et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003, 125:1085-1093.
18. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: Decoys and more. Nat Rev Immunol 2006, 6:907-918.
19. Yazdanbakhsh K., Rios M., Storry J.R., Kosower N., Parasol N., Chaudhuri A., Reid M.E. Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion 2000, 40:310-320.
20. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005, 16:687-694.
21. Rios M., Bianco C. The role of blood group antigens in infectious diseases. Semin Hematol 2000, 37:177-185.
22. Vergara C., Tsai Y.J., Grant A.V., Rafaels N., Gao L., Hand T., et al. Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. Am J Respir Crit Care Med 2008, 178:1017-1022.
23. Tournamille C., Colin Y., Cartron J.P., Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995, 10:224-228.
24. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976, 295:302-304.
25. He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008, 4:52-62.
26. Schnabel R.B., Baumert J., Barbalic M., Dupuis J., Ellinor P.T., Durda P., et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2009, 115:5289-5299.
27. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell Histology Activity Index and beyond. Hepatol 2000, 31:241-246.
28. Manning D.S., Afdhal N.H. Diagnosis and quantitation of fibrosis. Gastroenterology 2008, 134:1670-1681.
29. Schulz K.F., Grimes D.A. Case-control studies: Research in reverse. Lancet 2002, 359:431-434.
30. Seki E., De Minicis S., Gwak G.Y., Kluwe J., Inokuchi S., Bursill C.A., et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 2009, 119:1858-1870.
31. Asselah T., Bieche I., Laurendeau I., Paradis V., Vidaud D., Degott C., et al. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005, 129:2064-2075.
32. Wiederholt T., von Westernhagen M., Zaldivar M.M., Berres M.L., Schmitz P., Hellerbrand C., et al. Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Hum Immunol 2008, 69:861-866.
33. Berres M.L., Trautwein C., Zaldivar M.M., Schmitz P., Pauels K., Lira S.A., et al. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 2009, 390. Nos. :1039-45.
34. Holt A.P., Haughton E.L., Lalor P.F., Filer A., Buckley C.D., Adams D.H. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 2009, 136:705-714.
35. Schrage A., Wechsung K., Neumann K., Schumann M., Schulzke J.D., Engelhardt B., et al. Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines. Hepatol 2008, 48:1262-1272.
36. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 2009, 29:313-326.